A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy.

التفاصيل البيبلوغرافية
العنوان:	A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy.
المؤلفون:	Bishton MJ, Hicks RJ, Westerman DA, Prince MH, Wolf M, Seymour JF
المصدر:	Haematologica [Haematologica] 2008 May; Vol. 93 (5), pp. 789-90.
نوع المنشور:	Clinical Trial, Phase II; Letter; Multicenter Study
اللغة:	English
بيانات الدورية:	Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
أسماء مطبوعة:	Publication: 1999- : Pavia, Italy : Ferrata Storti Foundation Original Publication: Pavia [etc.]
مواضيع طبية MeSH:	Antibodies, Monoclonal/therapeutic use , Fluorodeoxyglucose F18/pharmacology , Iodine Radioisotopes/pharmacology , Lymphoma, Non-Hodgkin/therapy , Positron-Emission Tomography/methods , Radioimmunotherapy/methods, Adult ; Aged ; Antibodies, Monoclonal, Murine-Derived ; Antineoplastic Agents/therapeutic use ; Humans ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; Remission Induction ; Rituximab ; Time Factors ; Treatment Outcome
المشرفين على المادة:	0 (Antibodies, Monoclonal) 0 (Antibodies, Monoclonal, Murine-Derived) 0 (Antineoplastic Agents) 0 (Iodine Radioisotopes) 0Z5B2CJX4D (Fluorodeoxyglucose F18) 4F4X42SYQ6 (Rituximab)
تواريخ الأحداث:	Date Created: 20080503 Date Completed: 20080924 Latest Revision: 20151119
رمز التحديث:	20240829
DOI:	10.3324/haematol.12253
PMID:	18450737
قاعدة البيانات:	MEDLINE

Full Text Finder

الوصف
تدمد:	1592-8721
DOI:	10.3324/haematol.12253